95 related articles for article (PubMed ID: 3209992)
1. Alteration of infection pattern of duck hepatitis B virus by immunomodulatory drugs.
Fukuda R; Okinaga S; Akagi S; Hidaka M; Ono N; Fukumoto S; Shimada Y
J Med Virol; 1988 Dec; 26(4):387-96. PubMed ID: 3209992
[TBL] [Abstract][Full Text] [Related]
2. Transmission of duck hepatitis B virus from Chinese carrier ducks to Japanese ducklings: a study of viral DNA in serum and tissue.
Omata M; Yokosuka O; Imazeki F; Matsuyama Y; Uchiumi K; Ito Y; Mori J; Okuda K
Hepatology; 1984; 4(4):603-7. PubMed ID: 6745848
[TBL] [Abstract][Full Text] [Related]
3. A sequential study of viral DNA in serum in experimental transmission of duck hepatitis B virus.
Fukuda R; Fukumoto S; Shimada Y
J Med Virol; 1987 Apr; 21(4):311-20. PubMed ID: 3585287
[TBL] [Abstract][Full Text] [Related]
4. A sequential histologic and immunohistochemical study of duck hepatitis B virus infection in Pekin ducks.
Cullen JM; Marion PL; Newbold JE
Vet Pathol; 1989 Mar; 26(2):164-72. PubMed ID: 2540586
[TBL] [Abstract][Full Text] [Related]
5. Viral load in 1-day-old ducklings acutely infected with duck hepatitis B virus by different doses and routes of inoculation.
Chen ZY; Cheng AC; Wang MS; Xu DW; Jia R; Guo YF; Zeng W
Avian Pathol; 2009 Apr; 38(2):129-34. PubMed ID: 19322711
[TBL] [Abstract][Full Text] [Related]
6. Electron microscopic studies on duck hepatitis B virus particles in hepatocytes and sequential changes in various patterns of infection.
Okinaga S; Fukuda R; Fukumoto S; Shimada Y
Gastroenterol Jpn; 1991 Aug; 26(4):458-64. PubMed ID: 1916154
[TBL] [Abstract][Full Text] [Related]
7. [Attempt to cause hepatitis in duck hepatitis B virus carrier ducks by immunization with DHBV protein].
Kohge N; Fukuda R
Nihon Shokakibyo Gakkai Zasshi; 1992 May; 89(5):1242-51. PubMed ID: 1619786
[TBL] [Abstract][Full Text] [Related]
8. Antiviral effects of PNA in duck hepatitis B virus infection model.
Chen ZY; Cheng AC; Wang MS; Xu DW; Zeng W; Li Z
Acta Pharmacol Sin; 2007 Oct; 28(10):1652-8. PubMed ID: 17883953
[TBL] [Abstract][Full Text] [Related]
9. Characterization of age- and dose-related outcomes of duck hepatitis B virus infection.
Jilbert AR; Botten JA; Miller DS; Bertram EM; Hall PM; Kotlarski J; Burrell CJ
Virology; 1998 May; 244(2):273-82. PubMed ID: 9601498
[TBL] [Abstract][Full Text] [Related]
10. Natural duck hepatitis B virus infection in Australia.
Freiman JS; Cossart YE
Aust J Exp Biol Med Sci; 1986 Oct; 64 ( Pt 5)():477-84. PubMed ID: 3579742
[TBL] [Abstract][Full Text] [Related]
11. Reduced duck hepatitis B virus viraemia in ducklings coinfected with the immunodepressive reticuloendotheliosis virus.
Dixon RJ; Jones NF; Freiman JS
J Med Virol; 1990 Mar; 30(3):169-73. PubMed ID: 2160513
[TBL] [Abstract][Full Text] [Related]
12. Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection.
Le Mire MF; Miller DS; Foster WK; Burrell CJ; Jilbert AR
J Virol; 2005 Oct; 79(19):12242-52. PubMed ID: 16160150
[TBL] [Abstract][Full Text] [Related]
13. Contribution of aflatoxin B1 and hepatitis B virus infection in the induction of liver tumors in ducks.
Cova L; Wild CP; Mehrotra R; Turusov V; Shirai T; Lambert V; Jacquet C; Tomatis L; Trépo C; Montesano R
Cancer Res; 1990 Apr; 50(7):2156-63. PubMed ID: 2107970
[TBL] [Abstract][Full Text] [Related]
14. Epitope-specific antibody response to the surface antigen of duck hepatitis B virus in infected ducks.
Cheung RC; Trujillo DE; Robinson WS; Greenberg HB; Marion PL
Virology; 1990 Jun; 176(2):546-52. PubMed ID: 1693247
[TBL] [Abstract][Full Text] [Related]
15. Effects of acyclovir and vidarabin 5'-monophosphate on anti-duck hepatitis B virus in an in vitro culture system.
Motegi K
J Gastroenterol; 1995 Apr; 30(2):224-30. PubMed ID: 7539683
[TBL] [Abstract][Full Text] [Related]
16. Natural and experimental infection of wild mallard ducks with duck hepatitis B virus.
Lambert V; Cova L; Chevallier P; Mehrotra R; Trepo C
J Gen Virol; 1991 Feb; 72 ( Pt 2)():417-20. PubMed ID: 1993878
[TBL] [Abstract][Full Text] [Related]
17. Antiviral strategies in chronic hepatitis B virus infection: I. Establishment of an in vitro system using the duck hepatitis B virus model.
Bishop N; Civitico G; Wang YY; Guo KJ; Birch C; Gust I; Locarnini S
J Med Virol; 1990 Jun; 31(2):82-9. PubMed ID: 2388048
[TBL] [Abstract][Full Text] [Related]
18. [A study of duck hepatitis B virus infection in Chinese ducklings].
Leng J; Xu BD
Zhonghua Bing Li Xue Za Zhi; 1992 Jun; 21(3):160-3. PubMed ID: 1477940
[TBL] [Abstract][Full Text] [Related]
19. Antiviral efficacy against hepatitis B virus replication of oleuropein isolated from Jasminum officinale L. var. grandiflorum.
Zhao G; Yin Z; Dong J
J Ethnopharmacol; 2009 Sep; 125(2):265-8. PubMed ID: 19580857
[TBL] [Abstract][Full Text] [Related]
20. Liver disease associated with duck hepatitis B virus infection of domestic ducks.
Marion PL; Knight SS; Ho BK; Guo YY; Robinson WS; Popper H
Proc Natl Acad Sci U S A; 1984 Feb; 81(3):898-902. PubMed ID: 6583686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]